Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2019-04-10 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
关于募投项目结项并将节余募集资金永久补充流动资金的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Huabang Life Health Co., Ltd. regarding the completion of a fundraising investment project and the permanent allocation of surplus raised funds to supplement working capital. It details the use and surplus of raised funds, approvals from the board, supervisory board, independent directors, and the sponsor institution's verification. The document is relatively short (3157 characters) and primarily serves as a formal disclosure of the use of surplus fundraising proceeds rather than a full financial report or detailed financial statements. It does not contain comprehensive financial data or analysis typical of annual or interim reports. It is not a call transcript, earnings release, or management report. It is a regulatory announcement about the use of capital raised and related approvals, fitting best under Regulatory Filings (RNS) as it does not fit other more specific categories and is a formal compliance disclosure.
2019-04-10 Chinese
关于山东福尔有限公司业绩承诺完成情况的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion status of performance commitments related to a specific acquisition transaction by 华邦生命健康股份有限公司. It details the profit forecasts, actual audited profits for multiple years, and the fulfillment of profit compensation agreements. The document includes references to audit reports but does not itself contain full financial statements or comprehensive financial performance data typical of an Annual Report or Interim Report. The document is relatively short (3925 characters) and primarily serves to inform shareholders and the market about the status of performance commitments and related compensations. This type of document fits best under the category of a Regulatory Filing (RNS) as it is a regulatory announcement about a specific corporate event and related financial performance, but not a full financial report or earnings release.
2019-04-10 Chinese
同一控制下企业合并调整比较报表专项说明
Regulatory Filings
2019-04-10 Chinese
内部控制鉴证报告
Regulatory Filings
2019-04-10 Chinese
关于召开2018年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about the convening of the 2018 Annual General Meeting (AGM) of Huabang Life Health Co., Ltd. It includes details about the meeting date, voting procedures, agenda items to be discussed, and instructions for shareholders. The document does not contain the actual annual report or financial statements but rather the announcement and procedural information related to the AGM. The document length is 4427 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2019-04-10 Chinese
2018年度独立董事述职报告（郝颖）
Regulatory Filings
2019-04-10 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.